Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes

The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-establ...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Format: Online
Sprog:engelsk
Udgivet: 2022
Fag:
Online adgang:ONIX_20220916_9783036549965_62
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
_version_ 1869523533787299840
collection Directory of Open Access Books
description The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-established. In this regard, there have been increased efforts towards generating potentiated/activated MSCs with enhanced therapeutic efficacy. Research on the mechanisms for enhancing MSC potency and efficacy is an area of active study with great potential for translation into clinical settings. The purpose of this book is to bring together recent research from a broad range of topics relating to potentiation strategies for enhancing MSC therapeutic efficacy, including growth factor pre-conditioning, hypoxia, and 3D culture. The research compiled in this book increases the basic understanding of MSC culture techniques and describes some MSC preparations for potential novel therapeutic applications.
format Online
id doab-20.500.12854ir-92076
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
record_format ojs
spelling doab-20.500.12854ir-920762024-03-31T13:09:07Z Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes Ylostalo, Joni H. Durand, Nisha C. cell therapy immunomodulation polyunsaturated fatty acid CD206 phagocytosis mesenchymal stem cells Vadadustat AKB-6548 preconditioning priming secretome chemotaxis Wharton’s jelly mesenchymal stem cells umbilical cord oxygen conditions secretory profile neuroprotection mesenchymal stromal cells 3D culture neurospheres spheroids pluripotency neural quiescence mesothelioma malignant pleural mesothelioma (MPM) liver cirrhosis placenta-derived mesenchymal stem cells WKYMVm combination therapy iPSC-derived MSCs iMSC secretome pre-conditioning angiogenesis IFN-γ hypoxia potentiation of iMSC efficacy nanofiber-hydrogel composite spinal cord injury inflammation macrophages secondary injury astrocytes axon growth adipose tissue-derived stem cells (ASCs) autophagy rapamycin 3-methyladenine immunosuppression exosome engineered cardiac patches adipose-derived stem cell paracrine potential osteogenic differentiation hepatocyte growth factor fibroblast growth factor 2 thema EDItEUR::M Medicine and Nursing The regenerative and immunomodulatory properties of mesenchymal stem cells (MSCs) have made these cells the focus of multiple pre-clinical studies and clinical trials. While the results from these clinical studies have established that MSCs are safe, the efficacy of these cells is not as well-established. In this regard, there have been increased efforts towards generating potentiated/activated MSCs with enhanced therapeutic efficacy. Research on the mechanisms for enhancing MSC potency and efficacy is an area of active study with great potential for translation into clinical settings. The purpose of this book is to bring together recent research from a broad range of topics relating to potentiation strategies for enhancing MSC therapeutic efficacy, including growth factor pre-conditioning, hypoxia, and 3D culture. The research compiled in this book increases the basic understanding of MSC culture techniques and describes some MSC preparations for potential novel therapeutic applications. 2022-09-16T13:46:50Z 2022-09-16T13:46:50Z 2022 book ONIX_20220916_9783036549965_62 9783036549965 9783036549958 https://directory.doabooks.org/handle/20.500.12854/92076 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/5952 https://mdpi.com/books/pdfview/book/5952 10.3390/books978-3-0365-4995-8 10.3390/books978-3-0365-4995-8 MDPI - Multidisciplinary Digital Publishing Institute 9783036549965 9783036549958 204 Basel open access
spellingShingle cell therapy
immunomodulation
polyunsaturated fatty acid
CD206
phagocytosis
mesenchymal stem cells
Vadadustat
AKB-6548
preconditioning
priming
secretome
chemotaxis
Wharton’s jelly mesenchymal stem cells
umbilical cord
oxygen conditions
secretory profile
neuroprotection
mesenchymal stromal cells
3D culture
neurospheres
spheroids
pluripotency
neural
quiescence
mesothelioma
malignant pleural mesothelioma (MPM)
liver cirrhosis
placenta-derived mesenchymal stem cells
WKYMVm
combination therapy
iPSC-derived MSCs
iMSC secretome
pre-conditioning
angiogenesis
IFN-γ
hypoxia
potentiation of iMSC efficacy
nanofiber-hydrogel composite
spinal cord injury
inflammation
macrophages
secondary injury
astrocytes
axon growth
adipose tissue-derived stem cells (ASCs)
autophagy
rapamycin
3-methyladenine
immunosuppression
exosome
engineered cardiac patches
adipose-derived stem cell
paracrine potential
osteogenic differentiation
hepatocyte growth factor
fibroblast growth factor 2
thema EDItEUR::M Medicine and Nursing
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title_full Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title_fullStr Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title_full_unstemmed Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title_short Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
title_sort enhancing mesenchymal stem cells mscs for therapeutic purposes
topic cell therapy
immunomodulation
polyunsaturated fatty acid
CD206
phagocytosis
mesenchymal stem cells
Vadadustat
AKB-6548
preconditioning
priming
secretome
chemotaxis
Wharton’s jelly mesenchymal stem cells
umbilical cord
oxygen conditions
secretory profile
neuroprotection
mesenchymal stromal cells
3D culture
neurospheres
spheroids
pluripotency
neural
quiescence
mesothelioma
malignant pleural mesothelioma (MPM)
liver cirrhosis
placenta-derived mesenchymal stem cells
WKYMVm
combination therapy
iPSC-derived MSCs
iMSC secretome
pre-conditioning
angiogenesis
IFN-γ
hypoxia
potentiation of iMSC efficacy
nanofiber-hydrogel composite
spinal cord injury
inflammation
macrophages
secondary injury
astrocytes
axon growth
adipose tissue-derived stem cells (ASCs)
autophagy
rapamycin
3-methyladenine
immunosuppression
exosome
engineered cardiac patches
adipose-derived stem cell
paracrine potential
osteogenic differentiation
hepatocyte growth factor
fibroblast growth factor 2
thema EDItEUR::M Medicine and Nursing
topic_facet cell therapy
immunomodulation
polyunsaturated fatty acid
CD206
phagocytosis
mesenchymal stem cells
Vadadustat
AKB-6548
preconditioning
priming
secretome
chemotaxis
Wharton’s jelly mesenchymal stem cells
umbilical cord
oxygen conditions
secretory profile
neuroprotection
mesenchymal stromal cells
3D culture
neurospheres
spheroids
pluripotency
neural
quiescence
mesothelioma
malignant pleural mesothelioma (MPM)
liver cirrhosis
placenta-derived mesenchymal stem cells
WKYMVm
combination therapy
iPSC-derived MSCs
iMSC secretome
pre-conditioning
angiogenesis
IFN-γ
hypoxia
potentiation of iMSC efficacy
nanofiber-hydrogel composite
spinal cord injury
inflammation
macrophages
secondary injury
astrocytes
axon growth
adipose tissue-derived stem cells (ASCs)
autophagy
rapamycin
3-methyladenine
immunosuppression
exosome
engineered cardiac patches
adipose-derived stem cell
paracrine potential
osteogenic differentiation
hepatocyte growth factor
fibroblast growth factor 2
thema EDItEUR::M Medicine and Nursing
url ONIX_20220916_9783036549965_62